Thema
610
22
Recruitment Status: Authorised-recruitment may be ongoing or finished
Study Type: Interventional
Phase: Phase 4
12
Phase: Phase 3
6
Phase: Phase 2
4
Medical Condition: Acute respiratory distress syndrome (ARDS) associated with COVID-19 pneumonia;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Acute respiratory distress syndrome (ARDS) in patients affected by COVID-19 MedDRA version: 21.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Adult patients with SARS-CoV-2 infection (COVID19) requiring hospital admission for pneumonia. Who present pcr = 66 mg/L and =150 mg/L at inclusion or Pandemic score [13] on admission > 200 with pcr 9.7-149 mg/L at inclusion. WHO scale level 4 [14], with need for oxygen therapy in NG = 1 lpm to maintain saturation = 94%. ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: COVID 19;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: COVID-19;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Enfermedad en pacientes vulnerables con COVID-19 MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Hospitalized patients with COVID-19 requiring respiratory support MedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Hospitalized patients with Covid-19 pneumonia who do not require oxygen therapy on admission associated with at least two of the three following factors related with severe Covid-19: lactate dehydrogenase > 245 U/L, C-reactive protein > 100 mg/L and lymphocyte count < 800 cells/µL.;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Loss of smell after COVID-19 infection, persisting after 4 weeks;Therapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]
2
Medical Condition: SARS-CoV-2 infection (COVID-19) MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: acute hypoxemic respiratory failure (AHRF);Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2